KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Amgen (AMGN) Long-Term Debt Repayments (2016 - 2025)

Historic Long-Term Debt Repayments for Amgen (AMGN) over the last 15 years, with Q3 2025 value amounting to $1.5 billion.

  • Amgen's Long-Term Debt Repayments fell 3181.82% to $1.5 billion in Q3 2025 from the same period last year, while for Dec 2025 it was $5.0 billion, marking a year-over-year increase of 3888.89%. This contributed to the annual value of $5.0 billion for FY2025, which is 3888.89% up from last year.
  • Latest data reveals that Amgen reported Long-Term Debt Repayments of $1.5 billion as of Q3 2025, which was down 3181.82% from $1.0 billion recorded in Q2 2025.
  • Over the past 5 years, Amgen's Long-Term Debt Repayments peaked at $4.2 billion during Q4 2021, and registered a low of $704.0 million during Q1 2023.
  • Its 4-year average for Long-Term Debt Repayments is $1.8 billion, with a median of $1.5 billion in 2024.
  • Its Long-Term Debt Repayments has fluctuated over the past 5 years, first soared by 19333.33% in 2024, then tumbled by 3181.82% in 2025.
  • Quarter analysis of 4 years shows Amgen's Long-Term Debt Repayments stood at $4.2 billion in 2021, then crashed by 81.93% to $750.0 million in 2023, then soared by 193.33% to $2.2 billion in 2024, then plummeted by 31.82% to $1.5 billion in 2025.
  • Its Long-Term Debt Repayments was $1.5 billion in Q3 2025, compared to $1.0 billion in Q2 2025 and $2.5 billion in Q1 2025.